178 related articles for article (PubMed ID: 31816603)
21. Differentially expressed and activated proteins associated with non small cell lung cancer tissues.
Nigro E; Imperlini E; Scudiero O; Monaco ML; Polito R; Mazzarella G; Orrù S; Bianco A; Daniele A
Respir Res; 2015 Jun; 16(1):74. PubMed ID: 26104294
[TBL] [Abstract][Full Text] [Related]
22. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic Features and the Prognostic Implications of Long Noncoding RNA
Xiong F; Yin H; Zhang H; Zhu C; Zhang B; Chen S; Ling C; Chen X
Genet Test Mol Biomarkers; 2020 Jan; 24(1):47-53. PubMed ID: 31880484
[No Abstract] [Full Text] [Related]
24. Identification and characterization of miR-96, a potential biomarker of NSCLC, through bioinformatic analysis.
Cai T; Long J; Wang H; Liu W; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1213-1223. PubMed ID: 28656287
[TBL] [Abstract][Full Text] [Related]
25. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
27. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
28. Identification of prognostic biomarkers for major subtypes of non-small-cell lung cancer using genomic and clinical data.
Lathwal A; Kumar R; Arora C; Raghava GPS
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2743-2752. PubMed ID: 32661603
[TBL] [Abstract][Full Text] [Related]
29. Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues.
Chang CY; Chang SL; Leu JD; Chang YC; Hsiao M; Lin LT; Lin HN; Lee YJ
Oncol Rep; 2019 Aug; 42(2):805-816. PubMed ID: 31233187
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
31. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
32. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
[TBL] [Abstract][Full Text] [Related]
33. Differentially Expressed Gene Screening, Biological Function Enrichment, and Correlation with Prognosis in Non-Small Cell Lung Cancer.
Huang H; Huang Q; Tang T; Zhou X; Gu L; Lu X; Liu F
Med Sci Monit; 2019 Jun; 25():4333-4341. PubMed ID: 31181055
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and Prognosis of Non-small Cell Lung Cancer based on Machine Learning Algorithms.
Zhou Y; Dong Y; Sun Q; Fang C
Comb Chem High Throughput Screen; 2023; 26(12):2170-2183. PubMed ID: 36627791
[TBL] [Abstract][Full Text] [Related]
36. The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer.
Jiang F; Kuang B; Que Y; Lin Z; Yuan L; Xiao W; Peng R; Zhang X; Zhang X
Oncol Rep; 2016 Jan; 35(1):436-46. PubMed ID: 26531241
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
Gharabaghi MA
Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics approach for the validation of non-small cell lung cancer biomarkers.
Muller CB; de Barros RL; Moreira JC; Klamt F
Front Biosci (Elite Ed); 2011 Jan; 3(1):46-50. PubMed ID: 21196283
[TBL] [Abstract][Full Text] [Related]
39. Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).
Storti CB; de Oliveira RA; de Carvalho M; Hasimoto EN; Cataneo DC; Cataneo AJM; De Faveri J; Vasconcelos EJR; Dos Reis PP; Cano MIN
Exp Mol Pathol; 2020 Feb; 112():104354. PubMed ID: 31837325
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
